TABLE 1.

Participant group characteristics

Group	n	Age (Years)	Educ. (Years)	Sex	Chron. (Months)	Lat.	Lesion Volume (mm3)	TMT-A	MI	Rey AVLT: T5/Recall	Token test	BDI	IPI (%)
BDa	29	60.0 (11.9)	13.4 (2.2)	10F/19M	37.0 (43.3)	7L/9R/13B	56,507 (54,627)	34.6 (13.2)	100.1 (14.7)	12.2 (2.4)/9.5 (3.2)	41.6 (4.3)	5.8 (5.3)	52 (19)
NC	19	63.6 (7.1)	14.6 (1.9)	13F/6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	65 (18)

Notes: Means and standard deviations (in parentheses) are reported for demographic and neuropsychological variables. Note, neuropsychological variables and lesion-specific measures (laterality and chronicity) were only available for the lesion patient groups. There were no significant differences between NC and BD groups in age (t(46) = 1.31, p = 0.20) or education (t(46) = 1.83, p = 0.07), but there was a significant difference in sex (p = 0.02).

Abbreviations/variable descriptions: B, bilateral; BD, participants with brain injury; BDI, Beck Depression Inventory-II; Chron., chronicity or time between lesion onset and experimental testing in months; F, female; IPI, Imaginal Processes Inventory–daydreaming subscale percentage score; L, left; Lat., laterality of lesion; M, male; N/A, not applicable; NC, healthy comparison; R, right.

^aNeuropsychological data were not available for all mPFC participants from Bertossi and Ciaramelli (2016). Specifically, these participants were missing data for: TMT-A (n = 2); WMI (n = 6); Rey AVLT T5/Recall (n = 6); Token test (n = 3); BDI (n = 1).